Switzerland· 67615001

Ledaga

A chlormethine product containing chlormethinum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01AA05

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedLedagaATCL01AA05REGISTER NO.67615001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Chlormethine is registered in 12 of 19 countries.

Countries holding a registration under ATC L01AA05 (chlormethine), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Chlormethine · ATC L01AA05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
chlormethinum
Manufacturer
—
Country
Switzerland (CH)
ATC code
L01AA05
ATC class
Chlormethine
Defined daily dose
0.16 mg, T
Swissmedic category
A
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680676150013
    60 g
    CHF 1689.5

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

127 interactions on record for chlormethine.

Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Chlormethine · interactions on record

127 records

  • 32 severe
  • 78 moderate
  • 17 minor

Most severe, free to view

  • Nalidixic acidJ01MB02severe
  • ThiotepaL01AC01severe
  • CladribineL01BB04severe
  • Talimogene laherparepvecL01XL02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chlormethine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chlormethine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Ledaga
  • Liechtenstein · Ledaga
  • Norway · Ledaga

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9eff80f4-4269-4063-885e-14f87113dffd
GET /v1/drugs/9eff80f4-4269-4063-885e-14f87113dffd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "chlormethinum 160 mcg",
  "valid_from": "2026-05-01",
  "limitations": "[{\"description\":\"Nach Kostengutsprache durch den Krankenversicherer nach Konsultation des Vertrauensarztes zur topischen Behandlung des fachärztlich bestätigten kutanen T-Zell-Lymphoms (MF-CTCL) des Typs Mycosis fungoides bei Erwachsenen in den Stadien IA, IB, IIA nach mindestens einer vorangehenden topischen Therapie mit Steroiden.<br>\\nDie Einreichung eines Antrages um Kostengutsprache und die Erstverschreibung im Rahmen einer Kostengutsprache erfolgen ausschliesslich durch einen Facharzt für Hämatologie oder Onkologie, oder durch einen Facharzt für Dermatologie mit nachgewiesener Expertise in der Behandlung von kutanen T-Zell-Lymphomen, der an einer Weiterbildungsstätte der Kategorie A, B oder C mit Fachgebiet Dermatologie <b>und</b> Medizinische Onkologie oder Medizinische Onkologie oder Hämatologie tätig ist, die gleichzeitig mindestens einen dort tätigen Facharzt für Onkologie oder Hämatologie aufweist.<br> \\nDie Kostengutsprache wird für eine Behandlungsdauer von maximal 1 Jahr gewährt und kann maximal jährlich erneut beantragt werden.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"21369.01\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2026-05-01\",\"validTo\":\"2029-04-30\"}]",
  "galenic_form": "Gel 160 mcg/g",
  "therapeutic_area": null,
  "sl_inclusion_date": "2023-01-01",
  "self_retention_pct": 10
}

See everything about chlormethine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.